Pure Global
NCT05913765

Air Filtration for COPD in VA Population of Veterans

Air Filtration to Improve Indoor Air Quality (IAQ) and Chronic Obstructive Pulmonary Disease (COPD) Outcomes in a High-risk Urban Population of U.S. Military Veterans
Illinois Institute of Technology·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pulmonary Disease, Chronic Obstructive
Drug/Device/Intervention
Air cleaner
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Illinois Institute of Technology
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 11, 2023
End date
Dec 31, 2023
Enrollment
80 participants
Primary outcome

COPD exacerbations

Summary

The goal of this study is to investigate the effectiveness of stand-alone air filtration for
 improving indoor air quality (IAQ) and chronic obstructive pulmonary disease (COPD) outcomes
 in a high-risk urban cohort of 80 U.S. military veterans with COPD. Additional secondary
 goals of the study are to (1) investigate housing-related factors that may contribute to COPD
 exacerbation, (2) investigate the utility of using low-cost sensors for indoor air pollution
 epidemiology studies and for providing actionable or useful information on the quality of
 their indoor air to patients and their physicians, and (3) evaluate the costs and benefits of
 using stand-alone air filtration to improve IAQ and COPD outcomes.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05913765
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05913765 through Pure Global AI's free database. This phase not specified trial is sponsored by Illinois Institute of Technology and is currently Recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.